Dr. Hรถnle AG
HNL.DE
#9440
Rank
HK$0.37 B
Marketcap
HK$61.64
Share price
1.06%
Change (1 day)
-60.50%
Change (1 year)

P/E ratio for Dr. Hรถnle AG (HNL.DE)

P/E ratio as of December 2024 (TTM): -4.72

According to Dr. Hรถnle AG's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -4.71657. At the end of 2023 the company had a P/E ratio of -9.75.

P/E ratio history for Dr. Hรถnle AG from 2009 to 2024

PE ratio at the end of each year

Year P/E ratio Change
2023-9.7546.16%
2022-6.67-87.11%
2021-51.8-197.75%
202052.9141.03%
201922.012.39%
201819.54.77%
201718.78.75%
201617.236.1%
201512.6-17.2%
201415.249.72%
201310.28.66%
20129.3622.12%
20117.66-1.83%
20107.80-222.42%
2009-6.38-173.86%
20088.63-39.32%
200714.24.79%
200613.6-17.83%
200516.56.02%
200415.611.3%
200314.0-198.25%
2002-14.3

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.